Deep Dive: Vitamin K Shot Refusals and Rising Infant Bleeding Risk — Background, What Changed, Viewpoints, What to Watch

Deep Dive: Vitamin K Shot Refusals and Rising Infant Bleeding Risk

Parenting · 6 November 2026 · Deep dive

Background

Newborns are born with low vitamin K levels. The vitamin is essential for blood clotting. Without the single intramuscular shot given at birth, infants face a sharply elevated risk of vitamin K deficiency bleeding (VKDB) — which can cause gastrointestinal bleeding, intracranial hemorrhage, or death — especially in the first weeks to six months of life.

The shot has been standard in the U.S. for decades. CDC data historically showed that without it, roughly 1 in 59 infants experience serious bleeding, and about 1 in 5 of those die. Two doses of the MMR vaccine protect against measles; this single shot protects against a different, also preventable, threat.

What changed

Two studies published 5 November 2026 (one in JAMA Pediatrics) document a clear rise in both refusals and bleeding events:

• Truveta analysis of >1 million births: vitamin K refusals accelerated sharply in H1 2026, jumping >57% from January to June and rising from a 5.1% refusal rate at end-2024.
• Infants who did not receive the shot had a 47% higher risk of any bleeding in the first 6 months and more than twice the risk of brain bleeding compared with those who received it.
• The trend coincides with broader declines in trust around newborn interventions and vaccines.

A separate VCU-led study reached similar conclusions. Refusal rates that had been slowly climbing for years sped up markedly in 2026.

Competing viewpoints

Public health / AAP / CDC position: The shot is safe, effective, and one of the highest-yield preventive interventions in pediatrics. The observed rise in bleeding is the predictable consequence of rising refusals. Clear, consistent messaging is needed.

Some parent communities: Concerns about “unnecessary interventions,” ingredients, or a desire for a more “natural” birth experience. Some cite older European oral-regimen data or general vaccine skepticism. A minority of clinicians report pressure to skip the shot when parents request it.

Evidence does not support equivalent protection from oral vitamin K regimens used in some countries under U.S. practice conditions, and the intramuscular shot remains the AAP recommendation.

What to watch next

• Whether hospitals and state health departments begin tracking and publishing refusal rates in real time.
• Any AAP or CDC updated guidance or public campaigns in response to the JAMA data.
• Whether the same mistrust wave affects other routine newborn care (hepatitis B, erythromycin eye ointment, etc.).
• Longer-term outcome data as the 2026 birth cohort ages through the first six months.

Parents considering declining the shot should discuss the specific numerical risks with their pediatrician or hospital team before delivery.

Sources: Reuters (5 Nov 2026), JAMA Pediatrics studies, CDC, AAP, Truveta analysis.